Beova tablets 50 mcg for urination problems (vibegron, Gemtesa)
What are Beova (vibegron, Gemtesa) tablets for urination problems?
The active principle of Beova tablets is vibegran, a selective beta 3 adrenergic receptor agonist. It was developed in Japan by Kyorin Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd and Urovant Sciences and approved for medical use in 2018. Vibegran works by acting on beta 3 adrenergic receptors present in bladder, relaxing bladder smooth muscles and accumulating urine in the bladder.
Beova tablets are effective for the treatment of overactive bladder and such its symptoms as urinary urgency, frequent urination and urinary incontinence. Treatment with vibegron helps to reach a significant decrease in daily micturitions and number of urinary incontinence episodes.
Active principles: vibegron
Amount: 100 tablets
Maker: Kyorin Pharmaceuticals Co., Ltd., Kissei Pharmaceuticals Co., Ltd., Japan
- Overactive bladder,
- Urinary urgency,
- Frequent urination,
- Urinary incontinence.
How to take
Adults should take 1 tablet (50 mcg of vibegron) once a day, after meal.
Contraindications: do not use for pregnant or breastfeeding women.
If an allergic reaction occurs, patients needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.